Dentsply Sirona Q2 revenue slightly beats estimates
Dentsply Sirona Q2 revenue slightly beats estimates
Overview
Dental products maker's Q2 revenue declined 4.1% yr/yr but slightly beat analyst expectations
Adjusted EPS for Q2 was flat at $0.52 yr/yr
Company repurchased 1.3 mln shares and reiterated 2026 outlook
Outlook
Dentsply Sirona maintains 2026 net sales outlook of $3.5 bln to $3.6 bln
Company expects 2026 adjusted EPS of $1.40 to $1.50, excluding tariff refunds
Result Drivers
STRATEGIC INITIATIVES - Co said results reflect progress on distributor relationships, sales team realignment, and reinvestment as part of its Return-to-Growth Action Plan
SEGMENT PERFORMANCE - Revenue declined in most segments, with Orthodontic and Implant Solutions down 13.2% yr/yr, while Wellspect Healthcare grew 7.1%
Company press release: ID:nGNXbmxT6
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue | Slight Beat* | $898 mln | $889.81 mln (14 Analysts) |
*Applies to a deviation of less than 1%; not applicable for per-share numbers.
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 12 "hold" and 2 "sell" or "strong sell"
The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."
Wall Street's median 12-month price target for DENTSPLY SIRONA Inc. is $14.00, about 1.6% above its August 5 closing price of $13.78
The stock recently traded at 9 times the next 12-month earnings vs. a P/E of 8 three months ago
Reuters Recommended Reads
Aug 5 - Envista Q2 sales rise on segments growth
Aug 4 - Henry Schein raises annual forecasts on strong demand for dental supplies
Aug 6 - Germany's Carl Zeiss Meditec 9-month revenue falls 2.9%
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on DENTSPLY SIRONA
See all newsDentsply Sirona Inc. Reports Results For The Quarter Ended June 30: Earnings Summary
Dentsply Sirona Q2 revenue slightly beats estimates
U.S. STOCKS ON THE MOVE-Yum Brands, AMD, Nuvation Bio
U.S. STOCKS ON THE MOVE-Yum Brands, AMD, Nuvation Bio
U.S. STOCKS ON THE MOVE-Domino's, LXP Industrial, Yum Brands